Sonoma Pharmaceuticals, Inc. Common Stock Share Price
NASDAQ: SNOAHealthcare
Live Sonoma Pharmaceuticals, Inc. Common Stock Share Price Chart
O H L
Sonoma Pharmaceuticals, Inc. Common Stock Performance Overview
Days Range
▼
$1.25Low
$1.28High
Markets Today
| Previous Close | $1.26 |
|---|---|
| Open | $1.28 |
| Volume | 106,121 |
| Day's Range | $1.25 - $1.28 |
| 52W Range | $0.85 - $4.60 |
| Market Cap | $5.89 M |
Historical Performance
| 1M Returns | -5.38 |
|---|---|
| 3M Returns | +6.96 |
| 6M Returns | -50.20 |
| 1Y Returns | -71.13 |
| 5Y Returns | -98.85 |
| 10Y Returns | NA |
Sonoma Pharmaceuticals, Inc. Common Stock Fundamentals
| Market Cap | $5.89 M |
|---|---|
| Dividend yield | 0.00 |
| PE Ratio | 0.00 |
| PEG Ratio | N/A |
| Revenue | $19.53 M |
| ROE TTM | -0.85 |
| EPS TTM | $-1.22 |
| Quarterly Earnings Growth YOY | N/A |
| PB Ratio | 0.89 |
| EBITDA | $-3.28 M |
| Profit Margin | -16.26 |
| Market Cap | $5.89 M |
|---|---|
| Dividend yield | 0.00 |
| PE Ratio | 0.00 |
| PEG Ratio | N/A |
| Revenue | $19.53 M |
| ROE TTM | -0.85 |
| EPS TTM | $-1.22 |
|---|---|
| Quarterly Earnings Growth YOY | N/A |
| PB Ratio | 0.89 |
| EBITDA | $-3.28 M |
| Profit Margin | -16.26 |
Sonoma Pharmaceuticals, Inc. Common Stock Profit & Loss
Quarterly
| Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | |
|---|---|---|---|---|---|---|
| Total Revenue + | $3.75 M | $4.01 M | $5.60 M | $4.35 M | $5.56 M | $6.41 M |
| Gross Profit + | $1.53 M | $1.46 M | $2.12 M | $1.65 M | $2.18 M | $2.58 M |
| Operating Income | $147.00 K | -$1.09 M | -$337.00 K | -$678.00 K | -$1.31 M | -$40.00 K |
| EBITDA | $178.00 K | -$1.06 M | -$301.00 K | -$644.00 K | -$1.28 M | -$8.00 K |
| Interest Expense | $0 | $0 | $0 | $0 | $0 | $0 |
| Depreciation | $31.00 K | $36.00 K | $36.00 K | $34.00 K | $33.00 K | $32.00 K |
| Income Before Tax | -$528.00 K | -$1.24 M | -$731.00 K | -$949.00 K | -$497.00 K | -$330.00 K |
| Income Tax Expense | $248.00 K | -$1.00 K | -$197.00 K | -$130.00 K | $84.00 K | $0 |
| Net Income + | -$776.00 K | -$1.24 M | -$534.00 K | -$819.00 K | -$581.00 K | -$330.00 K |
| Net Profit Margin | -20.67% | -30.91% | -9.53% | -18.83% | -10.45% | -5.15% |
Sonoma Pharmaceuticals, Inc. Common Stock Financials Balance Sheet In USD
Quarterly
| Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | |
|---|---|---|---|---|---|---|
| Share Capital | $0 | $0 | $0 | $0 | $0 | $0 |
| Reserve & Surplus | -$202.18 M | -$202.62 M | -$202.95 M | -$203.59 M | -$204.22 M | -$204.32 M |
| Non-Current Liabilities | $5.19 M | $5.69 M | $5.75 M | $5.97 M | $6.03 M | $6.07 M |
| Current Liabilities | $4.10 M | $4.85 M | $4.32 M | $4.22 M | $4.83 M | $5.45 M |
| Total Liabilities | $9.28 M | $10.54 M | $10.07 M | $10.19 M | $10.87 M | $11.51 M |
| Fixed Assets | $225.00 K | $301.00 K | $284.00 K | $314.00 K | $310.00 K | $290.00 K |
| Current Assets | $12.65 M | $13.11 M | $12.50 M | $12.14 M | $12.10 M | $16.27 M |
| Total Assets | $13.69 M | $14.59 M | $13.86 M | $13.62 M | $13.96 M | $18.11 M |
Sonoma Pharmaceuticals, Inc. Common Stock Cash Flow
Quarterly
| Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | |
|---|---|---|---|---|---|---|
| Net Income | -$776.00 K | -$1.24 M | -$534.00 K | -$819.00 K | -$581.00 K | -$330.00 K |
| Operating Cash Flow | -$95.00 K | -$2.02 M | -$635.00 K | -$764.00 K | -$519.00 K | -$649.00 K |
| Investing Cash Flow | -$47.00 K | -$106.00 K | -$10.00 K | -$47.00 K | -$29.00 K | -$2.00 K |
| Financing Cash Flow | $242.00 K | -$58.00 K | -$62.00 K | $210.00 K | $387.00 K | $3.45 M |
| Change in Cash | $138.00 K | -$1.77 M | -$570.00 K | -$474.00 K | -$162.00 K | $2.94 M |
Sonoma Pharmaceuticals, Inc. Common Stock Return Calculator
The Sonoma Pharmaceuticals, Inc. Common Stock stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.
*Dollar Impact: The bonus return you make when the US Dollar rises against the Rupee; calculated on the full amount you walk away with, not just what you invested in.
Returns Estimator
Based on past performance of this fund
ENTER AMOUNT
$10,000
Select Duration
5Yrs
1 Yr5 Yrs
If you had invested $10,000 5 years ago, what would its value be today?$116
Invested Amount$10,000
Est. Returns$-9,884
About Sonoma Pharmaceuticals, Inc. Common Stock
Sonoma Pharmaceuticals Inc is a specialty pharmaceutical company operating in the United States. It is engaged in identifying, developing, and commercializing differentiated therapies for patients living with chronic skin conditions. The company focuses on the development and commercialization of therapeutic solutions in medical dermatology to treat skin conditions, such as acne, atopic dermatitis, and scarring. The key products of the company are Celacyn, Ceramax Skin Barrier Cream, Mondoxyne, Alevicyn, SebuDerm, Microcyn, and Microcyn which are available for various skin treatments such as scars, itchy skin, minor skin irritations, rashes, and others. The company derives revenue from the sale of products in the United States, Latin America, Europe, Asia, and other countries.
Popular Stocks
FAQs
What is the share price of Sonoma Pharmaceuticals, Inc. Common Stock today?
Sonoma Pharmaceuticals, Inc. Common Stock (SNOA) share price as of September 18, 2026 is $1.24. If you are investing from India, you can always check the valuation in the INR before investing.
Can Indian Investors purchase shares of Sonoma Pharmaceuticals, Inc. Common Stock?
Yes, Indian Investors can invest in the Sonoma Pharmaceuticals, Inc. Common Stock (SNOA) Share by opening an international trading account with Angel One.
How can I purchase Sonoma Pharmaceuticals, Inc. Common Stock shares in India?
Purchasing Sonoma Pharmaceuticals, Inc. Common Stock (SNOA) share from India can be done by: Directly: By opening an international trading account with Angel One. The process would include KYC verification. The account activation takes a few minutes to a few hours, after which you can start buying Sonoma Pharmaceuticals, Inc. Common Stock (SNOA) by making deposits in US dollars. Indirectly: By investing in mutual funds and Exchange Traded Funds (ETF) that offers exposure in global stocks.
Can I buy Fractional shares of Sonoma Pharmaceuticals, Inc. Common Stock?
Yes, you can purchase fractional shares of Sonoma Pharmaceuticals, Inc. Common Stock (SNOA) or any other US company shares in Angel One for any dollar amount.
What is the market capitalization value of Sonoma Pharmaceuticals, Inc. Common Stock?
The market capitalization of Sonoma Pharmaceuticals, Inc. Common Stock on September 18, 2026, is $5.89 M.
In which sector Sonoma Pharmaceuticals, Inc. Common Stock belongs?
Sonoma Pharmaceuticals, Inc. Common Stock operates in the Healthcare sector, specifically in the Healthcare industry.
What documents are required to invest in Sonoma Pharmaceuticals, Inc. Common Stock stocks?
In order to invest in Sonoma Pharmaceuticals, Inc. Common Stock (SNOA) you will need Proof of Identification (Aadhaar, PAN, Passport etc.) and Proof of Address (Aadhaar, Voter Card etc.). From start to end, the process is digital and can be seamless.
Diversify Your Portfolio with US Stocks
Invest in Wall Street Giants from India
